Christine Blasey Ford
#2,510
Most Influential Person Now
American research psychologist
Christine Blasey Ford's AcademicInfluence.com Rankings
Download Badge
Psychology
Christine Blasey Ford's Degrees
- PhD Psychology University of Southern California
- Masters Psychology Pepperdine University
- Bachelors Psychology University of North Carolina at Chapel Hill
Similar Degrees You Can Earn
Why Is Christine Blasey Ford Influential?
(Suggest an Edit or Addition)According to Wikipedia, Christine Margaret Blasey Ford is an American professor of psychology at Palo Alto University and a research psychologist at the Stanford University School of Medicine. She specializes in designing statistical models for research projects. During her academic career, Ford has worked as a professor at the Stanford University School of Medicine Collaborative Clinical Psychology Program.
Christine Blasey Ford's Published Works
Published Works
- A Developmental fMRI Study of the Stroop Color-Word Task (2002) (542)
- Centring in regression analyses: a strategy to prevent errors in statistical inference (2004) (463)
- Comorbid Depression, Chronic Pain, and Disability in Primary Care (2006) (451)
- Amygdalar activation associated with positive and negative facial expressions (2002) (286)
- Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism. (2018) (268)
- Premorbid Intellectual Functioning, Education, and Brain Size in Traumatic Brain Injury: An Investigation of the Cognitive Reserve Hypothesis (2003) (264)
- Posttraumatic Growth Following the Terrorist Attacks of September 11, 2001: Cognitive, Coping, and Trauma Symptom Predictors in an Internet Convenience Sample (2005) (221)
- Emotional attribution in high-functioning individuals with autistic spectrum disorder: a functional imaging study. (2004) (204)
- Acupuncture: a promising treatment for depression during pregnancy. (2004) (191)
- Psychiatric disorders and behavioral problems in children with velocardiofacial syndrome: usefulness as phenotypic indicators of schizophrenia risk (2002) (179)
- The association between patient characteristics and the therapeutic alliance in cognitive-behavioral and interpersonal therapy for bulimia nervosa. (2005) (176)
- Dropouts versus completers among chronically depressed outpatients. (2007) (168)
- Brain anatomy, gender and IQ in children and adolescents with fragile X syndrome. (2001) (164)
- Preliminary evidence that plasma oxytocin levels are elevated in major depression (2010) (157)
- Mifepristone versus Placebo in the Treatment of Psychosis in Patients with Psychotic Major Depression (2006) (141)
- The relationship between the therapeutic alliance and treatment outcome in two distinct psychotherapies for chronic depression. (2013) (139)
- A typology of non‐adherence in pediatric renal transplant recipients (2003) (137)
- Meditation with yoga, group therapy with hypnosis, and psychoeducation for long-term depressed mood: a randomized pilot trial. (2008) (130)
- Family environment of children and adolescents with bipolar parents. (2001) (125)
- Depression Subtypes in Predicting Antidepressant Response: A Report From the iSPOT-D Trial. (2015) (122)
- Velocardiofacial syndrome: are structural changes in the temporal and mesial temporal regions related to schizophrenia? (2001) (117)
- Supportive–expressive group therapy for primary breast cancer patients: a randomized prospective multicenter trial (2008) (108)
- Catastrophizing, depression and pain-related disability. (2011) (105)
- Neuropsychological correlates of psychotic features in major depressive disorders: a review and meta-analysis. (2004) (101)
- Effects of X-monosomy and X-linked imprinting on superior temporal gyrus morphology in Turner syndrome (2003) (94)
- Divalproex monotherapy in the treatment of bipolar offspring with mood and behavioral disorders and at least mild affective symptoms. (2003) (91)
- Characterization of children of bipolar parents by parent report CBCL. (2002) (85)
- Buprenorphine implants for treatment of opioid dependence: randomized comparison to placebo and sublingual buprenorphine/naloxone. (2013) (83)
- Functional brain imaging study of mathematical reasoning abilities in velocardiofacial syndrome (del22q11.2) (2001) (81)
- Attenuation of antidepressant and antisuicidal effects of ketamine by opioid receptor antagonism (2019) (80)
- Language skills in children with velocardiofacial syndrome (deletion 22q11.2). (2002) (77)
- Anxiety and Related Disorders and Concealment in Sexual Minority Young Adults. (2016) (74)
- Assessing insomnia severity in depression: comparison of depression rating scales and sleep diaries. (2005) (73)
- Magnetic Resonance Imaging Measures of Brain Structure to Predict Antidepressant Treatment Outcome in Major Depressive Disorder (2014) (73)
- Does Gender Moderate the Relationship Between Childhood Maltreatment and Adult Depression? (2011) (67)
- Relationships among depression, chronic pain, chronic disabling pain, and medical costs. (2009) (66)
- Temperament characteristics of child and adolescent bipolar offspring. (2003) (61)
- Efficacy and Safety of Mifepristone for the Treatment of Psychotic Depression (2011) (59)
- Cardiometabolic risk factors and obesity: does it matter whether BMI or waist circumference is the index of obesity? (2013) (57)
- A multisite trial of mifepristone for the treatment of psychotic depression: a site-by-treatment interaction. (2009) (50)
- Depression symptoms during pregnancy (2008) (49)
- Psychosocial Predictors of Resilience After the September 11, 2001 Terrorist Attacks (2009) (48)
- Patient's therapeutic skill acquisition and response to psychotherapy, alone or in combination with medication (2003) (48)
- Mifepristone treatment of olanzapine-induced weight gain in healthy men (2009) (45)
- Mifepristone Reduces Weight Gain and Improves Metabolic Abnormalities Associated With Risperidone Treatment in Normal Men (2010) (44)
- Therapeutic reactance as a predictor of outcome in the treatment of chronic depression. (2003) (39)
- Low circulating 25-hydroxyvitamin D concentrations are associated with defects in insulin action and insulin secretion in persons with prediabetes. (2015) (39)
- Functional brain imaging study of mathematical reasoning abilities in velocardiofacial syndrome (2001) (34)
- Relationships Among Depression, Chronic Pain, Chronic Disabling Pain, and Medical Costs (2009) (33)
- Cognitive Testing to Identify Children With ADHD Who Do and Do Not Respond to Methylphenidate (2017) (30)
- Selective Glucocorticoid Receptor (GR-II) Antagonist Reduces Body Weight Gain in Mice (2011) (30)
- Adult Attachment, Emotional Distress, and Interpersonal Problems in Alcohol and Drug Dependency Treatment (2007) (27)
- The efficacy of mifepristone in the reduction and prevention of olanzapine-induced weight gain in rats (2006) (26)
- Detecting critical decision points in psychotherapy and psychotherapy + medication for chronic depression. (2013) (25)
- Administration of a selective glucocorticoid antagonist attenuates electroconvulsive shock-induced retrograde amnesia (2012) (21)
- Discovery of a novel non-steroidal GR antagonist with in vivo efficacy in the olanzapine-induced weight gain model in the rat. (2012) (20)
- In search of moderators and mediators of hyperglycemia with atypical antipsychotic treatment. (2009) (20)
- A Randomized Trial of the Efficacy of Group Therapy in Changing Viral Load and CD4 Counts in Individuals Living with HIV Infection (2005) (18)
- Attrition from Alcohol and Drug Outpatient Treatment (2005) (18)
- From research to practice: teacher and pediatrician awareness of phenotypic traits in neurogenetic syndromes. (2005) (17)
- Beyond fasting plasma glucose: the association between coronary heart disease risk and postprandial glucose, postprandial insulin and insulin resistance in healthy, nondiabetic adults. (2013) (16)
- Corrigendum to “A Multisite Trial of Mifepristone for the Treatment of Psychotic Depression: A Site-by-Treatment Interaction” [Contemp. Clin. Trials 30 (2009)284–288] (2009) (12)
- Selective glucocorticoid receptor (type II) antagonists prevent weight gain caused by olanzapine in rats. (2011) (11)
- Psychological Flexibility and Set-Shifting Among Veterans Participating in a Yoga Program: A Pilot Study. (2018) (9)
- Chromosome 22q11 deletion and brain structure (2001) (7)
- Plasma glucose and insulin responses to mixed meals: Impaired fasting glucose re-visited (2011) (7)
- Contingency Table Analysis (2022) (7)
- A Program Evaluation Strategy in a Community-Based Behavioral Health and Education Services Agency for Children and Families (2002) (6)
- Self-reported depressive symptoms in active and retired professional hockey players. (2020) (4)
- Trough Plasma Concentrations of Mifepristone Correlate with Psychotic Symptom Reductions: A Review of Three Randomized Clinical Trials (2013) (3)
- Interpreting Ketamine's Opioid Receptor Dependent Effect: Response to Sanacora. (2019) (3)
- Girls With ADHD And Associated Behavioral Problems : Patterns of Comorbidity (2009) (2)
- Target Population, Dose, and Timing Considerations for Understanding Naltrexone's Subjective Effect: Response to Amiaz. (2019) (2)
- Rigorous Translational Models Are Key to Studying Ketamine's Antidepressant Mechanism: Response to Wang and Kaplin. (2019) (1)
- Homogeneity of Variance Tests (2016) (1)
- Equality of Means: Z- and t-tests, Balanced ANOVA (2016) (1)
- Original contribution Depression symptoms during pregnancy (2008) (0)
- The Pivotal Case: Intraclass Correlation (2016) (0)
- 4.67 Potential Mental Health Benefits of a Breakdancing Program for Inner-City Youth: A Pilot Study (2017) (0)
- Linear Regression Analysis (2016) (0)
- Reply (2008) (0)
- Preliminary communication Acupuncture: a promising treatment for depression during pregnancy (2004) (0)
- O19. Attenuation of Anti-Suicidal Effects of Ketamine by Opioid Receptor Antagonism (2019) (0)
This paper list is powered by the following services:
Other Resources About Christine Blasey Ford
What Schools Are Affiliated With Christine Blasey Ford?
Christine Blasey Ford is affiliated with the following schools: